The BNT162b2 KP.2 vaccine effectively prevents severe COVID-19 outcomes, including hospitalizations and ED or UC visits.
Children and adolescents had higher risks of vascular and inflammatory diseases after a first COVID diagnosis, as well as a higher risk of rare myocarditis or pericarditis after a first COVID vaccine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results